Compared to structural MRI and cerebrospinal fluid (CSF) tau biomarkers, FDG-PET abnormalities in the PCC/precuneus provide the strongest, earliest (preceding cognitive impairments) indication of individuals who will later progress to AD [58]. This evidence concerns the gene MAPT and Cognitive impairment.